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Abstract 15 
A study was carried out to investigate the combined effect of exogenous enzymes and 16 
probiotic supplementation on tilapia growth, intestinal morphology and microbiome 17 
composition. Tilapia (34.56 ± 0.05 g) were fed one of four diets (35% protein, 5% lipid); one 18 
of which was a control and the remaining three diets were supplemented with either enzymes 19 
(containing phytase, protease and xylanase), probiotic (containing Bacillus subtilis, B. 20 
licheniformis and B. pumilus) or enz-pro (the combination of the enzymes and probiotic). 21 
Tilapia fed diet supplemented with enz-pro performed better (P < 0.05) than tilapia fed the 22 
control and probiotic supplemented diets in terms of final body weight (FBW), specific 23 
growth rate (SGR), feed conversion ratio (FCR) and protein efficiency ratio (PER). The 24 
dietary treatments did not affect somatic indices. The serum lysozyme activity was 25 
significantly higher (P < 0.05) in tilapia fed the probiotic supplemented diet than of those fed 26 
the remaining experimental diets. The intestinal perimeter ratio was higher (P < 0.05) in 27 
tilapia fed enz-pro supplemented diet when compared to those fed with the control and 28 
probiotic supplemented diets. Goblet cells abundance, microvilli diameter and total 29 
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enterocyte absorptive surface was higher (P < 0.05) in tilapia fed diet supplemented with 30 
enz-pro than those fed the control diet. High-throughput sequencing revealed that majority of 31 
reads derived from the tilapia digesta belonged to members of Fusobacteria (predominantly 32 
Cetobacterium) distantly followed by Proteobacteria and Firmicutes. The alpha and beta 33 
diversities did not differ among dietary treatments indicating that the overall microbial 34 
community was not modified to a large extent by dietary treatment. In conclusion, 35 
supplementation of the diet with a combination of enzymes and probiotic is capable of 36 
improving tilapia growth and intestinal morphology without deleterious effect on the 37 
intestinal microbial composition. 38 
 39 
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1.0 Introduction 41 
The growth of aquaculture, the world’s fastest growing food production sector, is linked to 42 
population increase and consequently the intensification and diversification of aquaculture 43 
operations (Msangi et al., 2013). The rearing technologies for the intensive operations in 44 
aquaculture under poor management can be accompanied by sub-optimum environmental 45 
conditions as a result of overcrowding and overfeeding. These conditions may be stressful for 46 
fish, leading to decreased performance and subsequently compromised immune responses 47 
which leave fish prone to infection and disease by opportunistic pathogens. However, with 48 
the need to meet global animal protein demand and the growing pressure on fish farmers to 49 
reduce production cost without necessarily transferring the cost to the consumers, the 50 
stressful conditions associated with the intensive aquaculture operation is likely to continue in 51 
many parts of the world. The growing concept of immune-nutrition (production of high 52 
quality feed with optimal growth and immune boosting effects) could be of benefit to 53 
intensive aquaculture operations (Nakagawa et al., 2007, Kiron, 2012). 54 
The gastro-intestinal (GI) microbiota of fish has been reported to play a key role in nutrition 55 
and immunity. According to Nayak (2010), GI microbiota are involved in major nutritional 56 
functions which include digestion, nutrient utilisation and the production of specific amino 57 
acids, enzymes, short-chain fatty acids, vitamins and mineral availability. The nutritional role 58 
of GI microbiota includes the production of vitamins and the secretion of digestive enzymes 59 
that promote nutrient digestion as well as synthesise nutrients and metabolites required by 60 
fish (Okutani et al., 1967, Saha et al., 2006, Li et al., 2010, Liu et al., 2016). In addition, GI 61 
microbiota are capable of influencing immune status, disease resistance, survival, feed 62 
utilisation and may have a role in preventing pathogens from colonising the host (Denev et al., 63 
2009, Ringø et al., 2015). Apart from nutrition and immunological effects, fish GI microbiota 64 
have important functions in host metabolism, mucosal development and promote gut 65 
maturation (Bates et al., 2006, Rawls et al., 2004, Round and Mazmanian, 2009). 66 
It is well established that GI microbial communities are sensitive to rearing environment, 67 
seasonal and diet changes including the supplementation with probiotic (Dimitroglou et al., 68 
2011, Merrifield et al., 2010, Romero et al., 2014) and exogenous digestive enzymes 69 
(Bedford and Cowieson, 2012, Geraylou et al., 2012, Zhou et al., 2013, Jiang et al., 2014, 70 
Adeoye et al., 2016, Hu et al., 2016). Research into the use of exogenous digestive enzyme 71 
and probiotic supplements is increasing since aquafeed manufacturers are increasingly 72 
interested in producing ‘functional and environmentally friendly aquafeeds’. The potential 73 
effects of exogenous digestive enzymes (Kumar et al., 2012, Castillo and Gatlin, 2015, 74 
Lemos and Tacon, 2016) and probiotic (Pérez‐Sánchez et al., 2014) on fish have been 75 
reviewed as individual supplement. To the authors’ understanding, there is no previous report 76 
on combined used of exogenous digestive enzymes and probiotic as supplement in fish. 77 
However, the combined supplementation of exogenous enzymes and probiotic could result in 78 
a complimentary mode of actions: ability to produce fibre-degrading enzymes by probiotic 79 
may complement endogenous enzyme activity. On the other hand, exogenous digestive 80 
enzymes may increase availability of suitable substrate for probiotic as well as promote the 81 
growth of other beneficial bacteria (GI microbiota). 82 
Given the potential complimentary mode of actions of exogenous digestive enzymes and 83 
probiotic, the two products could improve the growth performance and health status of 84 
farmed fish when fed diets supplemented with both the enzymes and probiotic as a cocktail; 85 
Nile tilapia (Nile tilapia) is an important freshwater fish species of considerable economic 86 
value globally. Therefore, the objective of this study was to evaluate the combined effects of 87 
exogenous digestive enzymes and probiotic on growth, intestinal morphology and 88 
microbiome composition of Nile tilapia. 89 
2.0 Materials and methods 90 
2.1 Experimental design and diets preparation 91 
All experimental work involving fish was in accordance with the principles of the Animals 92 
(Scientific Procedures) Act 1986 and the Plymouth University Ethical Committee. 93 
The trial was conducted in a flow – through aquaculture system in King Mongkut’s Institute 94 
of Technology Ladkrabang - Thailand. The flow – through system contains 12 square 95 
concrete tanks (508 L capacity each) and were supplied with freshwater sourced from a local 96 
river system. Three hundred and sixty all male Nile tilapia (Oreochromis niloticus) of mean 97 
weight 34.56 ± 0.05 g obtained from Charoen Pokphand farm in Thailand were randomly 98 
distributed (30 fish per tank) into the 12 tanks after two weeks of acclimatization. The 99 
photoperiod and water temperature (30.34±0.15 °C) was maintained at ambient condition. 100 
The water pH (6.20±0.22) and dissolved oxygen levels (>5.0 mg L
-1
) were monitored daily 101 
using a HQ40d pH meter and dissolved oxygen multi-parameter meter (HACH Company, 102 
Loveland, USA). NH3 (0.304±0.08 mg L
-1
), NO2 (0.016±0.002 mg L
-1
) and NO3 (1.46±0.19 103 
mg L
-1
) were also monitored on a weekly basis using a nutrient analyser (SEAL AQ2 104 
Analyser, Hampshire, UK). A constant water flow of 4.9 L min
-1
 (per tank) was used during 105 
the experiment to maintain the water quality and ensure optimum conditions for the fish.  106 
A commercial diet (No. 461; 35% protein, 5% lipid) was obtained from INTEQC Feed Co. 107 
Ltd., Thailand and was used as basal formulation. The commercial diet was ground in a 108 
blender to powder and sieved to remove large particles. An enzyme cocktail (containing 109 
phytase, protease and xylanase), Sanolife PRO-F (a mixture of Bacillus subtilis, B. 110 
licheniformis and B. pumilus) and a combination of the enzyme cocktail and Sanolife PRO-F 111 
were added to the diets separately as stated in Table 1. The diets were coded as control (zero 112 
supplementation), enzymes (phytase, protease and xylanase supplementation), probiotic 113 
(probiotic supplementation) and enz-pro (enzymes and probiotic supplementation as a 114 
cocktail). The diets were mixed thoroughly for 15 min to ensure homogeneity. Warm water 115 
was added to form a consistency suitable for subsequent cold press extrusion. Afterwards, the 116 
diets were dried in an air convection oven set at 45 °C for 24 h. The basal diet served as the 117 
control and was prepared in the same way as those supplemented with the enzymes cocktail 118 
and probiotic, with the exception of the supplementation. Tilapia were fed the experimental 119 
diets for seven weeks at 3 % biomass day
-1
 in three equal rations. Daily feed was adjusted on 120 
a weekly basis by batch weighing following a 24 h deprivation period. 121 
2.2 Growth performance, feed utilisation and somatic indices 122 
Growth performance, feed utilisation and somatic indices were assessed by final body weight 123 
(FBW), specific growth rate (SGR), feed conversion ratio (FCR), protein efficiency ratio 124 
(PER), hepatosomatic index (HSI), viscero-somatic index (VSI) and condition factor (K), 125 
Calculations were carried out using the following formulae:                                          126 
SGR = 100 ((ln FBW – ln IBW)/T), where FBW = final body weight (g) and IBW = initial 127 
body weight (g)  128 
FCR = FI/WG, where FI = feed intake (g) and WG = wet weight gain (g) 129 
PER = WG/PI, where WG = wet weight gain (g) and PI = protein ingested (g), 130 
K = (100 x FW)/ FL
3
, where FL = FL = final length (cm)  131 
HSI = 100 (LW/ FBW), where LW = liver weight (g) and FBW = final body weight (g) 132 
VSI = 100 (VW/ FBW), where VW = visceral weight (g) 133 
All fish were euthanized with buffered tricaine methanesulfonate, MS222 (Pharmaq Ltd. 134 
Hampshire, UK) at a concentration of 200 mg L
-1
 followed by destruction of the brain prior 135 
to sampling. For proximate composition analysis (AOAC, 1995), at the onset of the trial 12 136 
fish were pooled to constitute three samples; at the end of the trial, three fish per tank were 137 
sampled. The fish were also used to record viscera weight and whole body weight in order to 138 
calculate the HSI and VSI. 139 
2.3 Haemato – immunological parameters 140 
At the end of the feeding trial, blood from three fish per tank (n = 9) was taken from the 141 
caudal arch using a 25 gauge needle and a 1 mL syringe after fish were anaesthetized with 142 
MS222 (Pharmaq Ltd. Hampshire, UK) at 150 mg L
-1
. Blood smears were prepared for 143 
determination of differential leucocyte counts and additional blood was left to clot for a 144 
period of 12 h (at 4°C) to isolate serum. Serum was isolated by centrifugation at 3600 g for 5 145 
min and was stored at −80 °C until further analysis. Haematocrit (measured and read as % 146 
packed cell volume; PCV), haemoglobin, red blood cells (RBC), serum lysozyme activity, 147 
white blood cells (WBC) and differential leucocyte proportions were determined according to 148 
standard methods as described by Rawling et al. (2009). 149 
2.4 Intestinal histology 150 
At the end of the trial, three fish per tank were sampled for histological appraisal (light, 151 
scanning electron and transmission electron microscopy) of the mid-intestine (n = 9). For 152 
light microscopy examination, the samples were fixed in 10% formalin, dehydrated in graded 153 
ethanol concentrations and embedded in paraffin wax. In each specimen, multiple sets of 154 
sections (5 mm thick) were stained with May-Grünwald Giemsa (MGG), haematoxylin and 155 
eosin (H&E) and Alcian-Blue-PAS (Dimitroglou et al., 2010, Ferguson et al., 2010). The 156 
intestinal perimeter ratios (arbitrary units, AU) were assessed after Dimitroglou et al. (2009) 157 
and the numbers of intraepithelial leucocytes (IELs) and goblet cells in the epithelium, across 158 
a standardized distance of 100 µm (10 folds per specimen), was then calculated by averaging 159 
the cell numbers from all specimens (Ferguson et al., 2010). For scanning electron 160 
microscopy (SEM) and transmission electron microscopy (TEM), samples were washed in 1 % 161 
S-carboxymethyl-L-cysteine for 30 seconds (SEM only) to remove mucus before fixing in 162 
2.5 % glutaraldehyde in sodium cacodylate buffer (0.1 M pH 7.2). samples were processed as 163 
described elsewhere (Dimitroglou et al., 2009) and screened with a JSM 6610 LV (Jeol, 164 
Tokyo, Japan) SEM or JEN 1400 (Jeol, Tokyo, Japan) TEM. The SEM images were analysed 165 
to assess microvilli count per µm
2
 (MCVT) and enterocyte apical area (EAA), µm
2
. The 166 
TEM images were analysed for microvilli length and diameter. All images were analysed 167 
with ImageJ version 1.47 (National Institute of Health, USA). 168 
Enterocyte total absorptive surface (ETAS), µm
2
 was calculated according to the following: 169 
ETAS = ((2π x ½ MVD x MVL) + (π x ½ MVD2)) x MVCT x EAA 170 
Where ETAS = enterocyte total absorptive surface (µm
2
); π = pie constant = 22/7; MVD = 171 
microvilli diameter (µm); MVL = microvilli length (µm); MVCT = microvilli count (No. 172 
/µm
2
); and EAA = enterocyte apical area. 173 
2.5 Intestinal microbiology 174 
The GI tract was aseptically removed and faecal matter from the mid-intestine was isolated 175 
and processed on an individual fish basis. DNA was extracted from 100 mg faecal matter 176 
after lysozyme (50 mg mL
-1 
in TE buffer) incubation for 30 min at 37 °C using PowerFecal
®
 177 
DNA Isolation Kit according to the manufacturer’s instructions. 178 
2.5.1 High-throughput sequencing analysis 179 
DNA extractions from the faecal matter were prepared for high-throughput sequencing as 180 
described by Standen et al. (2015).  In brief, PCR amplification of the 16S rRNA V1-V2 181 
region was conducted using primers 27F (5′-AGA GTT TGA TCM TGG CTC AG-3′) 182 
and 338R (5′-GCW GCC WCC CGT AGG WGT-3′). Each PCR contain 0.5 µL primer 183 
27F and 338R  (50pmol µL-1; Eurofins MWG, Germany), 25 µL MyTaq™  Red Mix 184 
(Bioline), 22 µL molecular grade water (Ambion) and 2 µL DNA template. Thermal cycling 185 
was conducted using a TC-512 thermal cycler (Techne, Staffordshire, UK) under the 186 
following conditions: initial denaturation at 94 °C for 7 minutes, then 10 cycles at 94 °C for 187 
30 seconds, touchdown of 1 °C per cycle from 62-53 °C for 30 seconds and 72 °C for 30 188 
seconds. Furthermore, 20 cycles were performed at 94 °C for 30 seconds, 53 °C for 30 189 
seconds and 72 °C for 30 seconds before a final extension for 7 minutes at 72 °C. The quality 190 
of the PCR products was checked using agarose gel electrophoresis. PCR products were 191 
purified (QIAquick PCR Purification Kit; Qiagen) and quantified using a Qubit
®
 2.0 192 
Fluorometer (Invitrogen). Before sequencing, the amplicons were assessed for fragment 193 
concentration using an Ion Library Quantitation Kit (Life Technologies TM, USA), the 194 
concentrations were then adjusted to 26 pM. Amplicons were attached to Ion Sphere Particles 195 
using Ion PGM Template OT2 400 kit (Life Technologies™, USA) according to the 196 
manufacturer’s instructions. Multiplexed sequencing was conducted using Ion Xpress 197 
Barcode Adapters (Life Technologies™) and a 318™ chip (Life Technologies™) on an Ion 198 
Torrent Personal Genome Machine (Life Technologies™). The sequences were binned by 199 
sample and filtered within the PGM software to remove low quality reads. Data were 200 
exported as FastQ files. 201 
Phylogenetic analyses were performed after the removal of reads with low quality scores (Q 202 
< 20) with FASTX-Toolkit (Hannon Laboratory, USA). Sequences were concatenated and 203 
sorted by sequence similarity into a single fasta file, denoised and analysed using the QIIME 204 
1.8.0 pipeline (Caporaso et al., 2010b). The USEARCH quality filter pipeline (Edgar, 2010) 205 
was used to filter out putative chimeras and noisy sequences and carry out OTU picking on 206 
the remaining sequences. The taxonomic affiliation of each OTU was determined based on 207 
the Greengenes database (DeSantis et al., 2006) using the RDP classifier (Wang et al., 2007) 208 
clustering the sequences at 95 % similarity with a 0.80 confidence threshold and a minimum 209 
sequence length of 150 base pairs. Non-chimeric OTUs were identified with a minimum 210 
pairwise identity of 95 %, and representative sequences from the OTUs were aligned using 211 
PyNAST (Caporaso et al., 2010a). To estimate bacterial diversity, the number of OTUs 212 
present in the samples was determined and a rarefaction analysis was performed by plotting 213 
the number of observed OTUs against the number of sequences. Good’s coverage, Shannon-214 
Wiener (diversity) and Chao1 (richness) indices were calculated. The similarities between the 215 
microbiota compositions of the intestinal samples were compared using weighted principal 216 
coordinate analysis (PCoA) and unweighted pair group method with arithmetic mean 217 
(UPGMA). 218 
2.7 Statistical analysis 219 
All data are presented as mean ± standard deviation. Statistical analysis (except high-220 
throughput sequencing) was carried out using SPSS for Windows (SPSS Inc., 22.0, Chicago, 221 
IL, USA). Data were checked for normality and equality of variance using Kolmogorov-222 
Smirnov and Bartlett’s test, respectively. Where normal assumptions were met, data were 223 
analysed using one-way analysis of variance (ANOVA) followed by a post-hoc Duncan test 224 
to determine significant differences. Where data violated these conditions after log 225 
transformation, a Kruskal- Wallis test was used. Differences between treatments were then 226 
determined using a Mann-Whitney U-test. For high-throughput sequence data, a Kruskal-227 
Wallis test was performed followed by pairwise comparison to compare alpha diversity 228 
metrics, and Vegan and ape packages of R were used to analyse the beta diversity of the 229 
groups. STAMP v2.1.3 and PRIMER V7 software (PRIMER-E Ltd., Ivybridge, UK) were 230 
used to distinguish differences at each taxonomic level for high-throughput sequence data. In 231 
all cases significance was accepted at P < 0.05. 232 
3.0 Results 233 
3.1 Growth performance, feed utilisation and somatic indices 234 
Growth performance and feed utilisation was assessed using tilapia FBW, SGR, FCR and 235 
PER (Table 2). Tilapia fed the diet supplemented with enz-pro performed better (P < 0.05) 236 
than tilapia fed the control and probiotic supplemented diets in term of FBW, SGR, FCR and 237 
PER. However, there was no difference (P > 0.05) in the performance of tilapia fed the diet 238 
supplemented with the enzymes and those fed diet supplemented with enz-pro in terms of 239 
FBW, SGR and FCR. The dietary treatment did not have a significant effect on the tilapia 240 
somatic indices. A 100% survival was recorded in all the treatments.  241 
3.2 Haemato – immunological parameters  242 
The haemato-immunological parameters of tilapia fed the experimental diets are displayed in 243 
Table 3. Serum lysozyme activity was significantly higher (P < 0.05) in tilapia fed the 244 
probiotic supplemented diet compared to serum lysozyme activity in tilapia fed the control 245 
and enz-pro treatments. No differences were observed between treatments in any other 246 
haematological parameter measured. 247 
3.3 Intestinal histology 248 
The mid-intestine of tilapia fed each of the experimental diets was examined by light 249 
microscopy (Figure 1), scanning and transmission electron microscopy (Figure ‎2). Tilapia 250 
from all treatments showed intact epithelial barriers with extensive mucosal folds extending 251 
into the lumen. Each fold consisted of simple lamina propria with abundant IELs and goblet 252 
cells (Figure ‎1). Tilapia fed the diet supplemented with enz-pro had significantly higher 253 
perimeter ratio and microvilli count (density) compared to tilapia fed probiotic supplemented 254 
and control diets (Table ‎4). Goblet cells abundance was significantly higher (P < 0.05) in 255 
tilapia fed the diet supplemented with enz-pro than those fed the control diet. Microvilli 256 
diameter of tilapia fed a diet supplemented with enz-pro was larger (P < 0.05) than tilapia fed 257 
the control diet. This translated to higher (P < 0.05) enterocyte absorptive area in tilapia fed 258 
diets supplemented with enzymes and a combination of both enzymes and probiotic than 259 
tilapia fed with the control diet. 260 
3.4 Intestinal microbiology 261 
A total of 536,602 sequence reads from the tilapia digesta were retained after trimming; after 262 
removing low quality reads, 24,521±14,451, 25,588±12,901, 32,708±10,388 and 263 
24,503±12,255 sequences for control, enzymes, probiotic and enz-pro treatments, 264 
respectively, were used for downstream analyses. Good’s coverage rarefaction curves for the 265 
treatments reached a plateau close to 1 (0.9994 – 0.9996) (Figure ‎1a and Table ‎5), an 266 
indication that sufficient coverage was achieved and that the OTUs detected in the samples 267 
are representative of the sampled population. 268 
The majority of reads derived from the tilapia digesta belonged to members of Fusobacteria (> 269 
89%) distantly followed by Proteobacteria (> 7%) and Firmicutes (> 0.4%) (Figure ‎3c). 270 
Table ‎6 shows the most abundant genera in tilapia digesta. Cetobacterium, Aquaspirillum, 271 
Edwardsiella and Plesiomonas as well as unknown genera from the order Clostridiales, 272 
family Clostridiaceae, class Gammaproteobacteria and order Aeromonadales were present in 273 
all treatments with Cetobacterium being dominant (> 84%) in all treatments. Cetobacterium 274 
accounted for 92.1%, 89.3%, 84.2% and 91% 16S rRNA reads in tilapia fed the control, 275 
enzymes, probiotic and enz-pro diets, respectively. Unknown genera from the families 276 
Leuconostocaceae and Methylocystaceae were present in the control, enzymes and probiotic 277 
treatments but absent in the enz-pro treatment. Weissella and an unknown genus from the 278 
family Methylocystaceae were present in the enzymes and probiotic treatments. Balneimonas 279 
was present in enzymes and enz-pro treatments. An unknown genus from the class 280 
Betaproteobacteria was also present in the control, probiotic and enz-pro treatments. 281 
However, Corynebacterium, Bacillus, Staphylococcus and Rhodobacter were only detected in 282 
probiotic treatment. 283 
The alpha diversity parameters are presented in Table ‎5. There was no significant difference 284 
between the treatments for the alpha diversity metrics assessed.  Figure ‎3b shows the beta 285 
diversity of the digesta through PCoA plots (based on Bray-Curtis dissimilarity matrix). The 286 
PCoA plot shows a spatial differentiation among the treatments. 287 
4.0 Discussion 288 
The previous reports on the use of exogenous digestive enzymes (Cao et al., 2007, Kumar et 289 
al., 2012, Castillo and Gatlin, 2015, Lemos and Tacon, 2016) and probiotic (Pandiyan et al., 290 
2013, Pérez‐Sánchez et al., 2014) as individual supplement in fish diet abounds. However, 291 
to the authors’ knowledge no research has been conducted previously on the combined 292 
effects of exogenous digestive enzymes and probiotic on growth, intestinal morphology and 293 
microbiome of Nile tilapia. In this study, Nile tilapia were fed diet supplemented with 294 
enzymes, probiotic or a combination of both the enzymes and probiotic. Given the potential 295 
complimentary modes of actions of exogenous digestive enzymes and probiotic, the two 296 
products (when used in combination) could offer more benefits than when used alone. This is 297 
confirmed in this study with improved growth performance in terms of FBW, SGR, FCR and 298 
PER observed in tilapia fed diet supplemented with enz-pro a combination of enzymes and 299 
probiotic. The enhanced growth performance could be attributed to the ability of probiotic to 300 
produce fibre-degrading enzymes that may complement endogenous enzyme activity for 301 
digestion in fish (Roy et al., 2009, Ray et al., 2010, Ray et al., 2012) as well as the external 302 
exogenous enzyme capacity to increase the availability of suitable substrates for probiotic 303 
action (Bedford and Cowieson, 2012). In addition, the enzymes could positively affect the gut 304 
microbiota through improved digestibility and enhanced nutrient absorption and assimilation. 305 
The indigestible NSPs and trypsin inhibitors that appear to induce necrotic enteritis in certain 306 
fish species are well known substrates for xylanase and protease enzymes respectively. 307 
Furthermore, xylanase may increase the digestion of NSPs (e.g. arabinoxylans) which could 308 
provide substrates for utilisation by gut bacteria (Bedford, 2000). 309 
The use of enzymes and probiotic as individual supplements in this study did not have 310 
significant effects on the growth performance of tilapia. This is somewhat contrary to the 311 
results of Hlophe‐Ginindza et al. (2015) who observed significantly improved growth 312 
performance in tilapia (Oreochromis mossambicus) when an exogenous enzyme cocktail, 313 
Natuzyme
®
 (containing protease, lipase, α-amylase, cellulase, amyloglucosidase, β-glucanase, 314 
pentosonase, hemicellulose, xylanase, pectinase, acid phosphatase and acid phytase) was 315 
added to a plant-based diet. The inconsistency in the findings may be due to lower application 316 
dosage of enzymes (75 mg kg
-1
 phytase, 300 mg kg
-1
 protease and 250 mg kg
-1
 xylanase) 317 
used in the current study compared to 500 mg kg
-1 
used by Hlophe‐Ginindza et al. (2015), 318 
in addition to the broader diversity of enzymes in Natuzyme
® 
or the different tilapia species. 319 
On the other hand, the lack of effect on tilapia growth fed probiotic supplemented diet in the 320 
current study is similar to the findings of Ng et al. (2014) who reported that dietary probiotic 321 
(B. subtilis, B. licheniformis or Pediococcus sp.) had no effect on growth or feeding 322 
efficiencies of tilapia. Shelby et al. (2006) also observed a non-effect of dietary Enterococcus 323 
faecium and Pediococcus acidilactici or mixtures of B. subtilis and B. licheniformis on 324 
growth of tilapia. However, B. subtilis when used solely as a dietary supplement was reported 325 
to be an effective growth promoter in tilapia (Aly et al., 2008), yellow croaker, Larimichthys 326 
crocea (Ai et al., 2011) and rohu, Labeo rohita (Nayak and Mukherjee, 2011). 327 
The improvement in intestinal morphology in the current study could be the result of 328 
complimentary changes to meet the increased rates of digestion and absorption after exposure 329 
to the diets. In this study, tilapia fed the diet supplemented with probiotic and enzymes 330 
presented a higher perimeter ratio, microvilli count (density) and larger diameter which 331 
translated to increased enterocyte absorptive area and subsequently resulted in the improved 332 
growth performance when compared with tilapia fed the control diet. This could be attributed 333 
to the combined effect of enzymes and probiotic to confer a superior beneficial effect than 334 
when used alone. However, there was no significant difference between intestinal histology 335 
of tilapia fed the control and probiotic supplemented diets. This is contrary to Standen et al. 336 
(2015) who reported increased population of IELs, a higher absorptive surface area index and 337 
higher microvilli density in the intestine of tilapia fed a diet supplemented with AquaStar® 338 
Growout, a multi-species probiotic containing Lactobacillus reuteri, Bacillus subtilis, 339 
Enterococcus faecium and Pediococcus acidilactici. This difference could be attributed to 340 
different probiotic composition as well as application dosage which is 20 mg kg
-1
 in the 341 
present study compared to 5 g kg
-1
 used by Standen et al. (2015). 342 
In this study, the dietary treatment did not have significant effect on the tilapia 343 
haematological parameters. Emadinia et al. (2014) also reported that supplementation of 344 
poultry diets with an enzyme cocktail (xylanase, β-glucanase, cellulase, pectinase, phytase, 345 
protease, lipase, and α-amylase) had no effects on haemato-immunological parameters. 346 
However, in the present study the serum lysozyme activity was significantly higher in tilapia 347 
fed the probiotic supplemented diet compared to those fed the control and enz-pro 348 
supplemented diets respectively. This is similar to the findings of Mandiki et al. (2011) who 349 
reported that dietary Bacillus probiotic have a stimulating effect on lysozyme activity in 350 
Eurasian perch, Perca fluviatilis. Standen et al. (2013) also reported that dietary probiotic are 351 
able to stimulate innate immune response in tilapia. 352 
Gut microbiota may function to prevent pathogens from colonization of the intestinal tract. 353 
The importance of commensal gut microbiota is highly important for normal functioning of 354 
the immune apparatus of the GI tract in fish (Rawls et al., 2004, Pérez et al., 2010, Ringø et 355 
al., 2015). The population size and composition of intestinal microbiota could influence the 356 
extent of nutrient digestion and absorption by the host  (Merrifield et al., 2010, Dimitroglou 357 
et al., 2011, Bedford and Cowieson, 2012, Ray et al., 2012). In addition, GI microbiota are 358 
understood to influence disease resistance, development, survival and feed utilisation (Denev 359 
et al., 2009). Jiang et al. (2014) reported that dietary supplementation of xylanase affected the 360 
abundance of Lactobacillus, Escherichia coli and Aeromonas in the intestine of juvenile Jian 361 
carp. The intestinal microbiota of grass carp fed dietary cellulase changed in respect to 362 
bacteria species and density (Zhou et al., 2013). Adeoye et al. (2016) also reported alteration 363 
in the intestinal bacterial community profile of tilapia fed carbohydrase supplemented diet. 364 
Similarly, several studies have reported the modulating effect of probiotic on fish GI 365 
microbiota (Dimitroglou et al., 2011, Pandiyan et al., 2013, Pérez‐Sánchez et al., 2014, 366 
Standen et al., 2015). However, in the present study exogenous enzymes and probiotic did not 367 
modify to a large extent microbial community of tilapia fed the experimental diets. 368 
Regardless of the dietary treatments, certain OTUs such as Clostridiales, Cetobacterium, 369 
Aquaspirillum, Gammaproteobacteria, Aeromonadales, Edwardsiella and Plesiomonas were 370 
found in the intestinal tract of tilapia, forming core microbiome. This is similar to findings by 371 
Larsen et al. (2014) who reported dominance of genus Cetobacterium in the gut of warm 372 
water fish species. Similarly, shared core gut microbiota was observed in zebrafish 373 
irrespective of geographical locations (Roeselers et al., 2011). Wong et al. (2013) also 374 
reported core intestinal microbiota in rainbow trout being resistant to variation in diet and 375 
rearing density. Similarly, the tilapia microbiome was quite stable and resistant to potential 376 
changes in community abundance and diversity in response to the dietary supplements used 377 
in this study. However, the functionality of the microbiome may have been altered and this 378 
may have contributed towards the improved performance of the tilapia fed the enzymes and 379 
probiotic cocktail. Future studies should include metagenomics and metatranscriptomics of 380 
the gut microbiome to investigate this hypothesis. 381 
In conclusion, supplementation of tilapia diets with a combination of enzymes and probiotic 382 
is capable of improving tilapia growth and intestinal histology without deleterious effect on 383 
the fish health or intestinal microbiota. It is pertinent therefore to consider these finding for 384 
the future development of diets specific for tilapia under a variety of culture conditions and 385 
stages of growth from fry to fingerlings and on-growing to production (harvest) size. 386 
  387 
Acknowledgment 388 
The authors are grateful to the Commonwealth Scholarship Commission in the UK and the 389 
School of Biological Sciences, Plymouth University for funding. The authors also thank 390 
DSM Nutritional Products and INVE Aquaculture for supplying the exogenous enzymes and 391 
probiotic respectively. Members of staff at Faculty of Agriculture, King Mongkut’s Institute 392 
of Technology Ladkrabang, Thailand as well as peers in the Aquatic Animal Nutrition and 393 
Health Research Group of Plymouth University are very much appreciated for technical 394 
supports.  395 
  396 
References 397 
ADEOYE, A., JARAMILLO-TORRES, A., FOX, S., MERRIFIELD, D. & DAVIES, S. 2016. 398 
Supplementation of formulated diets for tilapia (Oreochromis niloticus) with selected 399 
exogenous enzymes: overall performance and effects on intestinal histology and microbiota. 400 
Animal Feed Science and Technology, 215,pp. 133-143. 401 
AI, Q., XU, H., MAI, K., XU, W., WANG, J. & ZHANG, W. 2011. Effects of dietary 402 
supplementation of Bacillus subtilis and fructooligosaccharide on growth performance, 403 
survival, non-specific immune response and disease resistance of juvenile large yellow 404 
croaker, Larimichthys crocea. Aquaculture, 317, 155-161. 405 
ALY, S. M., ABD-EL-RAHMAN, A. M., JOHN, G. & MOHAMED, M. F. 2008. Characterization of 406 
some bacteria isolated from Oreochromis niloticus and their potential use as probiotics. 407 
Aquaculture, 277, 1-6. 408 
AOAC 1995. Official Methods of Analysis. Association of Official Analytical Chemists. Arlington, 409 
VA. 410 
BATES, J. M., MITTGE, E., KUHLMAN, J., BADEN, K. N., CHEESMAN, S. E. & GUILLEMIN, 411 
K. 2006. Distinct signals from the microbiota promote different aspects of zebrafish gut 412 
differentiation. Developmental biology, 297, 374-386. 413 
BEDFORD, M. 2000. Removal of antibiotic growth promoters from poultry diets: implications and 414 
strategies to minimise subsequent problems. World's Poultry Science Journal, 56, 347-365. 415 
BEDFORD, M. & COWIESON, A. 2012. Exogenous enzymes and their effects on intestinal 416 
microbiology. Animal Feed Science and Technology, 173, 76-85. 417 
CAO, L., WANG, W., YANG, C., YANG, Y., DIANA, J., YAKUPITIYAGE, A., LUO, Z. & LI, D. 418 
2007. Application of microbial phytase in fish feed. Enzyme and Microbial Technology, 40, 419 
497-507. 420 
CAPORASO, J. G., BITTINGER, K., BUSHMAN, F. D., DESANTIS, T. Z., ANDERSEN, G. L. & 421 
KNIGHT, R. 2010a. PyNAST: a flexible tool for aligning sequences to a template alignment. 422 
Bioinformatics, 26, 266-267. 423 
CAPORASO, J. G., KUCZYNSKI, J., STOMBAUGH, J., BITTINGER, K., BUSHMAN, F. D., 424 
COSTELLO, E. K., FIERER, N., PENA, A. G., GOODRICH, J. K. & GORDON, J. I. 2010b. 425 
QIIME allows analysis of high-throughput community sequencing data. Nature methods, 7, 426 
335-336. 427 
CASTILLO, S. & GATLIN, D. M. 2015. Dietary supplementation of exogenous carbohydrase 428 
enzymes in fish nutrition: a review. Aquaculture, 435, 286-292. 429 
DENEV, S., STAYKOV, Y., MOUTAFCHIEVA, R. & BEEV, G. 2009. Microbial ecology of the 430 
gastrointestinal tract of fish and the potential application of probiotics and prebiotics in finfish 431 
aquaculture. International aquatic research, 1, 1-29. 432 
DESANTIS, T. Z., HUGENHOLTZ, P., LARSEN, N., ROJAS, M., BRODIE, E. L., KELLER, K., 433 
HUBER, T., DALEVI, D., HU, P. & ANDERSEN, G. L. 2006. Greengenes, a chimera-434 
checked 16S rRNA gene database and workbench compatible with ARB. Applied and 435 
environmental microbiology, 72, 5069-5072. 436 
DIMITROGLOU, A., MERRIFIELD, D., MOATE, R., DAVIES, S., SPRING, P., SWEETMAN, J. 437 
& BRADLEY, G. 2009. Dietary mannan oligosaccharide supplementation modulates 438 
intestinal microbial ecology and improves gut morphology of rainbow trout,(Walbaum). 439 
Journal of animal science, 87, 3226-3234. 440 
DIMITROGLOU, A., MERRIFIELD, D. L., CARNEVALI, O., PICCHIETTI, S., AVELLA, M., 441 
DANIELS, C., GÜROY, D. & DAVIES, S. J. 2011. Microbial manipulations to improve fish 442 
health and production–a Mediterranean perspective. Fish & Shellfish Immunology, 30, 1-16. 443 
DIMITROGLOU, A., MERRIFIELD, D. L., SPRING, P., SWEETMAN, J., MOATE, R. & DAVIES, 444 
S. J. 2010. Effects of mannan oligosaccharide (MOS) supplementation on growth 445 
performance, feed utilisation, intestinal histology and gut microbiota of gilthead sea bream 446 
(Sparus aurata). Aquaculture, 300, 182-188. 447 
EDGAR, R. C. 2010. Search and clustering orders of magnitude faster than BLAST. Bioinformatics, 448 
26, 2460-2461. 449 
EMADINIA, A., TOGHYANI, M., GHEISARI, A., TABEIDIAN, S. A., ALE SAHEB FOSOUL, S. 450 
S. & MOHAMMADREZAEI, M. 2014. Effect of wet feeding and enzyme supplementation 451 
on performance and immune responses of broiler chicks. Journal of Applied Animal Research, 452 
42, 32-37. 453 
FERGUSON, R., MERRIFIELD, D. L., HARPER, G. M., RAWLING, M. D., MUSTAFA, S., 454 
PICCHIETTI, S., BALCÀZAR, J. L. & DAVIES, S. J. 2010. The effect of Pediococcus 455 
acidilactici on the gut microbiota and immune status of on‐growing red tilapia (Oreochromis 456 
niloticus). Journal of Applied Microbiology, 109, 851-862. 457 
GERAYLOU, Z., SOUFFREAU, C., RURANGWA, E., D'HONDT, S., CALLEWAERT, L., 458 
COURTIN, C. M., DELCOUR, J. A., BUYSE, J. & OLLEVIER, F. 2012. Effects of 459 
arabinoxylan-oligosaccharides (AXOS) on juvenile Siberian sturgeon (Acipenser baerii) 460 
performance, immune responses and gastrointestinal microbial community. Fish & shellfish 461 
immunology, 33, 718-724. 462 
HLOPHE‐GININDZA, S. N., MOYO, N. A., NGAMBI, J. W. & NCUBE, I. 2015. The effect of 463 
exogenous enzyme supplementation on growth performance and digestive enzyme activities 464 
in Oreochromis mossambicus fed kikuyu‐based diets. Aquaculture Research. 465 
HU, J., RAN, C., HE, S., CAO, Y., YAO, B., YE, Y., ZHANG, X. & ZHOU, Z. 2016. Dietary 466 
microbial phytase exerts mixed effects on the gut health of tilapia: a possible reason for the 467 
null effect on growth promotion. The British journal of nutrition, 1. 468 
JIANG, T. T., FENG, L., LIU, Y., JIANG, W. D., JIANG, J., LI, S. H., TANG, L., KUANG, S. Y. & 469 
ZHOU, X. Q. 2014. Effects of exogenous xylanase supplementation in plant protein‐470 
enriched diets on growth performance, intestinal enzyme activities and microflora of juvenile 471 
Jian carp (Cyprinus carpio var. Jian). Aquaculture Nutrition, 20, 632-645. 472 
KIRON, V. 2012. Fish immune system and its nutritional modulation for preventive health care. 473 
Animal Feed Science and Technology, 173, 111-133. 474 
KUMAR, V., SINHA, A., MAKKAR, H., DE BOECK, G. & BECKER, K. 2012. Phytate and phytase 475 
in fish nutrition. Journal of animal physiology and animal nutrition, 96, 335-364. 476 
LARSEN, A., MOHAMMED, H. & ARIAS, C. 2014. Characterization of the gut microbiota of three 477 
commercially valuable warmwater fish species. Journal of applied microbiology, 116, 1396-478 
1404. 479 
LEMOS, D. & TACON, A. G. 2016. Use of phytases in fish and shrimp feeds: a review. Reviews in 480 
Aquaculture. 481 
LI, H., ZHENG, Z., CONG-XIN, X., BO, H., CHAO-YUAN, W. & GANG, H. 2010. Isolation of 482 
cellulose—producing microbes from the intestine of grass carp (Ctenopharyngodon idellus). 483 
Chinese Fishes. Springer. 484 
LIU, H., GUO, X., GOONERATNE, R., LAI, R., ZENG, C., ZHAN, F. & WANG, W. 2016. The gut 485 
microbiome and degradation enzyme activity of wild freshwater fishes influenced by their 486 
trophic levels. Scientific Reports, 6. 487 
MANDIKI, S., MILLA, S., WANG, N., BLANCHARD, G., DJONKACK, T., TANASCAUX, S. & 488 
KESTEMONT, P. 2011. Effects of probiotic bacteria on growth parameters and immune 489 
defence in Eurasian perch Perca fluviatilis L. larvae under intensive culture conditions. 490 
Aquaculture Research, 42, 693-703. 491 
MERRIFIELD, D., BRADLEY, G., BAKER, R. & DAVIES, S. 2010. Probiotic applications for 492 
rainbow trout (Oncorhynchus mykiss Walbaum) II. Effects on growth performance, feed 493 
utilization, intestinal microbiota and related health criteria postantibiotic treatment. 494 
Aquaculture nutrition, 16, 496-503. 495 
MSANGI, S., KOBAYASHI, M., BATKA, M., VANNUCCINI, S., DEY, M. & ANDERSON, J. 496 
2013. Fish to 2030: Prospects for fisheries and aquaculture. World Bank Report. 497 
NAKAGAWA, H., SATO, M. & GATLIN III, D. M. 2007. Dietary supplements for the health and 498 
quality of cultured fish, Cabi. 499 
NAYAK, S. K. 2010. Role of gastrointestinal microbiota in fish. Aquaculture Research, 41, 1553-500 
1573. 501 
NAYAK, S. K. & MUKHERJEE, S. C. 2011. Screening of gastrointestinal bacteria of Indian major 502 
carps for a candidate probiotic species for aquaculture practices. Aquaculture Research, 42, 503 
1034-1041. 504 
NG, W.-K., KIM, Y.-C., ROMANO, N., KOH, C.-B. & YANG, S.-Y. 2014. Effects of Dietary 505 
Probiotics on the Growth and Feeding Efficiency of Red Hybrid Tilapia, Oreochromis sp., 506 
and Subsequent Resistance to Streptococcus agalactiae. Journal of Applied Aquaculture, 26, 507 
22-31. 508 
OKUTANI, K., KAWADA, I. & KIMATA, M. 1967. The chitinolytic enzyme present in the 509 
digestive tracts of yellow tail. Bull. Jap. Soc. Sc. Fish, 33, 848-852. 510 
PANDIYAN, P., BALARAMAN, D., THIRUNAVUKKARASU, R., GEORGE, E. G. J., 511 
SUBARAMANIYAN, K., MANIKKAM, S. & SADAYAPPAN, B. 2013. Probiotics in 512 
aquaculture. Drug Invention Today, 5, 55-59. 513 
PÉREZ‐SÁNCHEZ, T., RUIZ‐ZARZUELA, I., BLAS, I. & BALCÁZAR, J. L. 2014. Probiotics 514 
in aquaculture: a current assessment. Reviews in Aquaculture, 6, 133-146. 515 
PÉREZ, T., BALCÁZAR, J., RUIZ-ZARZUELA, I., HALAIHEL, N., VENDRELL, D., DE BLAS, I. 516 
& MÚZQUIZ, J. 2010. Host–microbiota interactions within the fish intestinal ecosystem. 517 
Mucosal immunology. 518 
RAWLING, M. D., MERRIFIELD, D. L. & DAVIES, S. J. 2009. Preliminary assessment of dietary 519 
supplementation of Sangrovit® on red tilapia (Oreochromis niloticus) growth performance 520 
and health. Aquaculture, 294, 118-122. 521 
RAWLS, J. F., SAMUEL, B. S. & GORDON, J. I. 2004. Gnotobiotic zebrafish reveal evolutionarily 522 
conserved responses to the gut microbiota. Proceedings of the National Academy of Sciences 523 
of the United States of America, 101, 4596-4601. 524 
RAY, A., GHOSH, K. & RINGØ, E. 2012. Enzyme‐producing bacteria isolated from fish gut: a 525 
review. Aquaculture Nutrition, 18, 465-492. 526 
RAY, A. K., ROY, T., MONDAL, S. & RINGØ, E. 2010. Identification of gut‐associated amylase, 527 
cellulase and protease ‐ producing bacteria in three species of Indian major carps. 528 
Aquaculture Research, 41, 1462-1469. 529 
RINGØ, E., ZHOU, Z., VECINO, J., WADSWORTH, S., ROMERO, J., KROGDAHL, Å., OLSEN, 530 
R., DIMITROGLOU, A., FOEY, A. & DAVIES, S. 2015. Effect of dietary components on 531 
the gut microbiota of aquatic animals. A never‐ending story? Aquaculture Nutrition. 532 
ROESELERS, G., MITTGE, E. K., STEPHENS, W. Z., PARICHY, D. M., CAVANAUGH, C. M., 533 
GUILLEMIN, K. & RAWLS, J. F. 2011. Evidence for a core gut microbiota in the zebrafish. 534 
The ISME journal, 5, 1595-1608. 535 
ROMERO, J., RINGØ, E. & MERRIFIELD, D. L. 2014. The Gut Microbiota of Fish. Aquaculture 536 
Nutrition: Gut Health, Probiotics and Prebiotics, 75-100. 537 
ROUND, J. L. & MAZMANIAN, S. K. 2009. The gut microbiota shapes intestinal immune responses 538 
during health and disease. Nature Reviews Immunology, 9, 313-323. 539 
ROY, T., MONDAL, S. & RAY, A. K. 2009. Phytase‐producing bacteria in the digestive tracts of 540 
some freshwater fish. Aquaculture research, 40, 344-353. 541 
SAHA, S., ROY, R. N., SEN, S. K. & RAY, A. K. 2006. Characterization of cellulase‐producing 542 
bacteria from the digestive tract of tilapia, Oreochromis mossambica (Peters) and grass carp, 543 
Ctenopharyngodon idella (Valenciennes). Aquaculture Research, 37, 380-388. 544 
SHELBY, R. A., LIM, C., YILDIRIM-AKSOY, M. & DELANEY, M. A. 2006. Effects of probiotic 545 
diet supplements on disease resistance and immune response of young Nile tilapia, 546 
Oreochromis niloticus. Journal of Applied Aquaculture, 18, 23-34. 547 
STANDEN, B., RAWLING, M., DAVIES, S., CASTEX, M., FOEY, A., GIOACCHINI, G., 548 
CARNEVALI, O. & MERRIFIELD, D. 2013. Probiotic Pediococcus acidilactici modulates 549 
both localised intestinal-and peripheral-immunity in tilapia (Oreochromis niloticus). Fish & 550 
shellfish immunology, 35, 1097-1104. 551 
STANDEN, B., RODILES, A., PEGGS, D., DAVIES, S., SANTOS, G. & MERRIFIELD, D. 2015. 552 
Modulation of the intestinal microbiota and morphology of tilapia, Oreochromis niloticus, 553 
following the application of a multi-species probiotic. Applied microbiology and 554 
biotechnology, 99, 8403-8417. 555 
WANG, Q., GARRITY, G. M., TIEDJE, J. M. & COLE, J. R. 2007. Naive Bayesian classifier for 556 
rapid assignment of rRNA sequences into the new bacterial taxonomy. Applied and 557 
environmental microbiology, 73, 5261-5267. 558 
WONG, S., WALDROP, T., SUMMERFELT, S., DAVIDSON, J., BARROWS, F., KENNEY, P. B., 559 
WELCH, T., WIENS, G. D., SNEKVIK, K. & RAWLS, J. F. 2013. Aquacultured rainbow 560 
trout (Oncorhynchus mykiss) possess a large core intestinal microbiota that is resistant to 561 
variation in diet and rearing density. Applied and environmental microbiology, 79, 4974-4984. 562 
ZHOU, Y., YUAN, X., LIANG, X.-F., FANG, L., LI, J., GUO, X., BAI, X. & HE, S. 2013. 563 
Enhancement of growth and intestinal flora in grass carp: the effect of exogenous cellulase. 564 
Aquaculture, 416, 1-7. 565 
  566 
Tables 567 
Table 1. Dietary formulation and proximate composition (g kg
-1
) of experimental diets 568 
 Control Enzymes Probiotics Enz-pro 
Commercial feed
a
 1000 999.94 999.98 998.92 
Phytase
b 
(mg) 0 7.5 0 7.5 
Protease
c 
(mg) 0 30 0 30 
Xylanase
d 
(mg) 0 25 0 25 
Probiotics
e 
(mg) 0 0 20 20 
Total 1000 1000 1000 1000 
Proximate composition (% as fed basis) 
Moisture  8.03±0.04 6.87±0.14 8.06±0.06 6.63±0.09 
Protein  34.32±0.28 34.78±0.09 34.43±0.13 34.56±0.08 
Lipid  5.49±0.04 5.33±0.10 5.38±0.70 5.22±0.08 
Ash  13.13±0.11 13.13±0.17 13.16±0.04 13.4±0.04 
Energy (MJ kg
-1
) 17.06±0.00 17.56±0.1 17.31±0.4 17.66±2.1 
Fibre  3.65±0.06 3.15±0.12 3.15±0.07 3.21±0.05 
     
a
No. 461, INTEQC Feed Co Ltd., Thailand 569 
b
RONOZYME
®
 Hiphos (contains 10,000FYT g
-1
) from DSM Nutritional Products 570 
c
RONOZYME
®
 ProAct (contains 75,000 PROT g
-1
) from DSM Nutritional Products 571 
d
RONOZYME
®
 WX (contains 1000 FXU g
-1
) from DSM Nutritional Products 572 
e
Sanolife PRO-F (contains 1 x 10
10
 CFU g
-1  
B. subtilis, B. licheniformis and B. pumilus) from 573 
INVE Aquaculture 574 
  575 
Table 2. Growth performance, feed utilisation and somatic indices of tilapia fed the 576 
experimental diets 577 
 Control Enzymes Probiotics Enz-pro 
IBW (g fish
-1
) 34.5±0.18 34.54±0.05 34.6±0.13 34.61±0.29 
FBW (g fish
-1
) 138.04±2.44
a
 139.49±2.83
ab
 136.61±1.34
a
 143.42±3.06
b
 
SGR (% day
-1
) 3.30±0.05
a
 3.32±0.04
ab
 3.27±0.02
a
 3.38±0.04
b
 
FI (g fish
-1
) 92.24±0.92 92.83±1.22 92.35±0.27 93.00±1.39 
FCR 0.94±0.02
a
 0.93±0.02
ab
 0.96±0.02
a
 0.9±0.01
b
 
PER 2.49±0.06
ab
 2.53±0.06
b
 2.42±0.05
a
 2.63±0.02
c
 
HSI 3.19±0.23 3.18±0.26 2.86±0.46 3.10±0.02 
VSI 21.72±0.66 21.44±2.96 23.40±1.31 21.83±1.61 
K-factor 2.11±0.08 2.06±0.05 2.10±0.07 2.06±0.04 
Survival (%) 100 100 100 100 
Means in the same row with different superscripts are significantly different (P < 0.05). IBW, 578 
initial mean body weight; FI, daily feed intake; FBW, final mean body weight; SGR, specific 579 
growth rate; FCR, feed conversion ratio; PER, protein efficient ratio; HSI, hepatosomatic 580 
index and VSI, viscera-somatic index. 581 
 582 
 583 
 584 
  585 
Table 3. Haemato – immunological parameters of tilapia fed the experimental diets 586 
 Control Enzymes Probiotics Enz-pro 
Haematocrit, (%PCV) 40.11±3.34 39.11±1.35 41.67±3.48 39.66±1.53 
Haemoglobin, (g dL
-1
) 11.35±1.21 10.66±0.91 11.93±2.50 11.33±0.22 
RBC (10
6
 µL
-1
) 1.74±0.10 2.02±0.47 1.92±0.32 1.87±0.09 
RBC (10
3
 µL
-1
) 20.28±1.34 20.37±4.00 20.59±0.08 20.64±2.82 
MCV (fL) 232.53±12.95 207.97±36.80 223.30±34.69 213.04±12.66 
MCH (pg) 66.10±4.60 56.25±6.66 62.76±7.18 61.00±4.19 
MCHC (g dL
-1
) 28.29±1.59 27.25±1.59 28.75±3.98 28.62±0.97 
Lymphocytes (%) 90.43±2.57 91.40±2.38 91.77±1.30 89.43±3.54 
Monocytes (%) 5.14±1.87 4.26±2.06 3.94±0.54 5.74±1.97 
Granulocytes (%) 4.42±0.70 4.34±0.33 4.29±0.76 4.83±1.62 
Serum lysozyme (U) 115.31±22.87
a
 154.21±24.93
ab
 170.39±22.98
b
 127.97±6.43
a
 
Figures in each row with different superscript are significantly different (P < 0.05).  587 
RBC, red blood cells; WBC, leucocytes; MCV, mean corpuscular volume (haematocrit 588 
(%PCV) x 10)/RBC 106 µL
-1
); MCH, mean corpuscular haemoglobin (haemoglobin (g dL
-1
) 589 
x 10)/RBC (106 µL
-1
); MCHC, mean corpuscular haemoglobin concentration (haemoglobin 590 
(g dL
-1
) x 100)/haematocrit (%PCV); %, mean percentage of total leucocytes; U, lysozyme 591 
activity mL
-1 
min
-1
 592 
  593 
Table 4. Intestinal histology of tilapia fed the experimental diets 594 
    Control Enzymes Probiotics Enz-pro 
Perimeter ratio  5.30±0.7
a
 5.84±0.4
ab
 5.22±0.5
a
 6.72±0.8
b
 
Goblet cells (per 100µm) 3.85±0.6
a
 4.66±0.6
ab
 4.55±0.6
ab
 5.11±0.2
b
 
IELs (per 100µm) 29.16±5 29.48±2 29.85±5 28.68±4 
Microvilli count (per µm
2
)  91.82±4
a
 110.30±2.2
bc
 103.75±5.9
b
 115.17±6.5
c
 
Enterocyte apical area (µm
2
) 11.30±1.3 12.39±1.4 12.06±1 12.47±2.1 
Microvilli length (µm) 1.24±0.04 1.35±0.03 1.32±0.2 1.27±0.04 
Microvilli diameter (µm) 0.117±0.01
a
 0.123±0.01
ab
 0.123±0.01
ab
 0.130
b
 
ETAS(µm
2
) 499.9±82
a
 762.17±85
b
 674.55±145
ab
 773.7±151
b
 
Values with different superscripts indicate significant differences (P < 0.05). IELs, 595 
Intraepithelial leucocytes; ETAS = enterocyte total absorptive surface (µm
2
). 596 
 597 
  598 
Table 5. Number  of reads, reads assigned to OTUs, Good’s coverage and alpha diversity indices of allochthonous intestinal microbiota 599 
composition between control, enzymes, probiotics and enz-pro treatments after 7 weeks of experimental feeding 600 
 Reads        
(pre-trimming) 
Reads assigned 
(post trimming) 
Good’s coverage Observed species Shanon’s diversity 
index 
Chao1 (Richness) Index 
Control  41,748±22,108  24,521±14,451 0.9994±0.0001 75.90±9.54 2.82±0.10 92.00±11.19 
Enzymes 42,898±20,096 25,588±12,901 0.9995±0.0007 75.18±14.54 2.78±0.14 88.77±12.04 
Probiotics 57,638±15,492 32,708±10,388 0.9996±0.0002 76.95±17.94 3.20±0.60 87.28±16.15 
Enz-pro 40,244±18,342 24,503±12,255 0.9994±0.0001 72.12±7.10 2.94±0.25 88.04±8.18 
There were no significant differences between the treatments 601 
 602 
  603 
Table 6. Abundance of the OTUs present in digesta samples (expressed as %). General level 604 
identification is presented where possible  605 
OTU Control Enzymes Probiotics Enz-Pro 
Cetobacterium 92.1±3.8 89.3±4.8 84.21±4.3 91.0±3.4 
Plesiomonas 4.0±2.5 7.7±4.4 5.6±1.9 4.0±2.2 
Unknown genus from order Aeromonadales 2.4±2.4 1.0±0.5 3.1±2.4 2.7±2.4 
Aquaspirillum 0.9±0.4 0.4±0.3 1.2±1.3 0.7±0.7 
Unknown genus from family Leuconostocaceae 0.1±0.1 0.2±0.3 1.5±2.9 0.0±0.0 
Unknown genus from family Leuconostocaceae 0.1±0.2 0.2±0.3 2.0±3.9 0.0±0.0 
Edwardsiella 0.2±0.1 0.6±0.7 1.2±1.4 0.3±0.1 
Unknown genus from order Clostridiales 0.1±0.1 0.2±0.1 0.1±0.0 0.1±0.1 
Unknown genus from family Clostridiaceae 0.1±0.1 0.1±0.1 0.1±0.1 0.1±0.1 
Unknown genus from class Gammaproteobacteria 0.1±0.0 0.1±0.1 0.3±0.2 0.1±0.1 
Unknown genus from class Betaproteobacteria 0.2±0.3 0.0±0.0 0.6±1.2 0.1±0.0 
Weissella 0.0±0.0 0.1±0.2 0.7±1.4 0.0±0.0 
Unknown genus from family Methylocystaceae 0.1±0.1 0.2±0.4 0.3±0.6 0.0±0.0 
Balneimonas 0.0±0.0 0.1±0.1 0.0±0.0 0.6±1.2 
Unknown genus from family Methylocystaceae 0.0±0.0 0.1±0.1 0.2±0.3 0.0±0.0 
Rhodobacter 0.0±0.0 0.0±0.0 0.4±0.9 0.0±0.0 
Leuconostoc 0.0±0.0 0.1±0.1 0.1±0.2 0.0±0.0 
Staphylococcus 0.0±0.0 0.0±0.0 0.2±0.4 0.0±0.0 
Corynebacterium 0.0±0.0 0.0±0.0 0.1±0.2 0.0±0.0 
Bacillus 0.0±0.0 0.0±0.0 0.1±0.2 0.0±0.0 
There was no significant difference across the treatments  606 
Figures 607 
 608 
Figure 1. Light micrograph of the mid-intestine of tilapia fed control (a & b), enzymes (c & 609 
d), probiotics (e & f) and enz-pro (g & h) diets. Goblet cells (arrows) and abundant IELs 610 
(arrowheads) are present in the epithelia. Abbreviations are E enterocytes, LP lamina propria 611 
and L lumen. Light microscopy staining: [a, c, e & g] H & E; [b, d, f & h] Alcian Blue-PAS. 612 
Scale bars = 100 µm. 613 
 614 
Figure ‎2. Scanning electron (a, c, e & g) and transmission electron (b, d, f & h) micrographs 615 
of the mid-intestine of tilapia fed control (a & b), enzymes (c & d), probiotics (e & f) and 616 
enz-pro (g & h) diets. Abbreviations are L lumen, TJ tight junction, MV microvilli. Scale 617 
bars = 1 µm (a, c, e & g), 2 µm (b, d, f & h). 618 
 619 
 620 
Figure 3. 16S rRNA V1-V2 high-throughput sequencing libraries of digesta from the tilapia intestine. (a) Good’s coverage rarefaction curves of 621 
the tilapia digesta; (b) PCoA plots using Bray-Curtis dissimilarity matrix where data points represent samples from tilapia fed a control diet (red 622 
triangles), enzymes diet (blue squares), probiotic diet (green triangles) and enz-pro diet (orange circles); and (c) proportion of 16S rRNA reads 623 
from the tilapia digesta by dietary treatment assigned at the phylum level. 624 
